# FDA Inspection 1194330 - Nomax Inc - December 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/nomax-inc/5c9f6dab-e7c7-4940-b461-1c4fcfe29c7d
Source feed: FDA_Inspections

> FDA Inspection 1194330 for Nomax Inc on December 02, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194330
- Company Name: Nomax Inc
- Inspection Date: 2022-12-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1229313 - 2024-02-16](https://www.keypedia.com/records/fda_inspections/nomax-inc/ba76d325-301e-4164-83db-3d85abc64918)
- [FDA Inspection 1229313 - 2024-02-16](https://www.keypedia.com/records/fda_inspections/nomax-inc/679c0057-a474-4296-9444-a67b95ec8efa)
- [FDA Inspection 1180777 - 2022-06-24](https://www.keypedia.com/records/fda_inspections/nomax-inc/1ea2de94-9731-4349-a9b1-458d5b71018a)
- [FDA Inspection 1180777 - 2022-06-24](https://www.keypedia.com/records/fda_inspections/nomax-inc/bb70c0df-3c37-4fb5-855f-06bcbdfd2347)
- [FDA Inspection 1042641 - 2018-02-01](https://www.keypedia.com/records/fda_inspections/nomax-inc/809614da-ac0c-4d58-a7b3-9078f1ebfdeb)

Company: https://www.keypedia.com/companies/nomax-inc/269d696c-bdf9-48a2-9ce3-2ba71aef35aa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c